{
  "pmid": "29236629",
  "uid": "29236629",
  "title": "The Fate of FDA Postapproval Studies.",
  "abstract": "",
  "authors": [
    {
      "last_name": "Schwartz",
      "fore_name": "Lisa M",
      "initials": "LM",
      "name": "Lisa M Schwartz",
      "affiliations": [
        "Dartmouth Institute for Health Policy and Clinical Practice, Lebanon, NH"
      ]
    },
    {
      "last_name": "Woloshin",
      "fore_name": "Steven",
      "initials": "S",
      "name": "Steven Woloshin",
      "affiliations": [
        "Dartmouth Institute for Health Policy and Clinical Practice, Lebanon, NH"
      ]
    },
    {
      "last_name": "Moore",
      "fore_name": "Thomas J",
      "initials": "TJ",
      "name": "Thomas J Moore",
      "affiliations": [
        "Institute for Safe Medication Practices, Alexandria, VA"
      ]
    }
  ],
  "journal": {
    "title": "The New England journal of medicine",
    "iso_abbreviation": "N Engl J Med",
    "issn": "1533-4406",
    "issn_type": "Electronic",
    "volume": "377",
    "issue": "24",
    "pub_year": "2017",
    "pub_month": "Dec",
    "pub_day": "14"
  },
  "start_page": "2405",
  "pages": "2405",
  "language": "eng",
  "publication_types": [
    "Letter",
    "Comment"
  ],
  "keywords": [
    "Drug Approval",
    "Humans",
    "United States Food and Drug Administration"
  ],
  "article_ids": {
    "pubmed": "29236629",
    "doi": "10.1056/NEJMc1713794",
    "pii": "10.1056/NEJMc1713794#SA2"
  },
  "doi": "10.1056/NEJMc1713794",
  "dates": {
    "completed": "2017-12-15",
    "revised": "2018-12-02"
  },
  "chemicals": [],
  "grants": [],
  "search_metadata": {
    "search_type": "all_publications",
    "retrieved_date": "2025-07-30T14:57:03.548941",
    "pmid": "29236629"
  }
}